Companies: 10,660     total market cap: ยฃ102.941 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณ$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Neurocrine Biosciences
NBIX
#1548
Rank
ยฃ10.36 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
ยฃ103.95
Share price
2.58%
Change (1 day)
-14.04%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2025 (TTM): ยฃ0.44 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are ยฃ2.68 Billion. In 2024 the company made an earning of ยฃ0.45 Billion, an increase over its 2023 earnings that were of ยฃ0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.44 B-1.9%
2024 ยฃ0.45 B96.41%
2023 ยฃ0.22 B41.13%
2022 ยฃ0.16 B73.74%
2021 ยฃ93.44 M-8.82%
2020 ยฃ0.10 B77.78%
2019 ยฃ57.64 M49.83%
2018 ยฃ38.47 M-142.57%
2017 -ยฃ90.38 Million-14.73%
2016 -ยฃ0.11 Billion53.15%
2015 -ยฃ69.21 Million46.25%
2014 -ยฃ47.33 Million29.66%
2013 -ยฃ36.5 Million-3530.8%
2012 ยฃ1.06 M-95.73%
2011 ยฃ24.92 M
2009 -ยฃ35.04 Million-45.38%
2008 -ยฃ64.14 Million-58.87%
2007 -ยฃ0.16 Billion87.3%
2006 -ยฃ83.25 Million351.97%
2005 -ยฃ18.42 Million-52.09%
2004 -ยฃ38.45 Million-10.98%
2003 -ยฃ43.19 Million
2001 -ยฃ32.24 Million
1999 -ยฃ14.54 Million108.32%
1998 -ยฃ6.98 Million
1996 ยฃ2.13 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.70 B 1,932.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.21 B 184.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ16.53 B 3,758.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ19.2 M-95.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ30.69 Million-107.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ37.13 M-91.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ3.53 Million-100.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
ยฃ1.16 B 171.24%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com